Bacteriocin DNA nanocomplexes as immunotherapeutic carriers
dc.citation.epage | 137 | en_US |
dc.citation.spage | 136 | en_US |
dc.contributor.author | Yağcı, Fuat Cem | en_US |
dc.contributor.author | Güçlüler, Gözde | en_US |
dc.contributor.author | Kıran, F. | en_US |
dc.contributor.author | Gürsel, İhsan | en_US |
dc.coverage.spatial | Mainz, Germany | en_US |
dc.date.accessioned | 2019-07-08T06:31:44Z | |
dc.date.available | 2019-07-08T06:31:44Z | |
dc.date.issued | 2012-05 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description | Conference Name: 10th CIMT Annual Meeting, Towards Next-Generation Cancer Immunotherapy, 2012 | en_US |
dc.description | Date of Conference: 23-25 May 2012 | en_US |
dc.description.abstract | Synthetic oligodeoxynucleotides (CpG-ODNs) and bacterial DNA containing unmethylated CpG dinucleotides (CpG motifs) are clinical candidates as anti-cancer agents, immune adjuvants, anti-allergens, and stand alone immunoprotective agents. Two different classes of CpG-ODNs were identified for clinical applications. B-Class ODNs, also known as K-type CpG ODN, have phosphorothioate backbones and potent B- cell activators. A-Class ODNs (or D-type ODNs) have mixed backbone and flanking G-runs at their 3`and 5-ends. | en_US |
dc.identifier.uri | http://hdl.handle.net/11693/52144 | |
dc.language.iso | English | en_US |
dc.publisher | Association for Cancer Immunotherapy | en_US |
dc.source.title | Abstract Book 2012, 10th CIMT Annual Meeting | en_US |
dc.title | Bacteriocin DNA nanocomplexes as immunotherapeutic carriers | en_US |
dc.type | Conference Paper | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Bacteriocin_DNA_nanocomplexes_as_immunotherapeutic_carriers.pdf
- Size:
- 179.78 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: